Replies to post #383744 on Amarin Corp Plc (AMRN)

[rosemountbomber]

Good post JRoon.

[Skipperdog11]

Well said!

[ramfan60]

Once upon a time Steve Jobs, Bill Gates, and Elon Musk had no experience either. They gained it along the way. As frustrating as this is for those of us wanting to get rich quickly, it won't be happening overnight. We need to progress country by country and every country has a different agenda. I'll take a buyout along the way or other approved indications but I'm assuming this is a slow slog.

[shadolane]

What you describe is a plausible description of what usually happens and what happened at AMRN.

Your statement that "it was game over for their hopeful buyout" leaves one wondering what if anything is left for shareholders.

With that conclusion if accurate we have little to no hope of getting a significantly higher pps based on the actions of the company.

Is Denner our final shot at that in your opinion?

Or will the EU be the saving grace in spite of AMRN management?

[biotech_researcher]

JRoon71, this should be a sticky post for those that happen to wander in now.. Well done..

[Birdbrain Ideas]

My problem with Amarin at the moment is that the message that the public, investors and worst of all, doctors, hear is not coming from Amarin. It's coming from Amarin's critics. And, left unchecked, the critics who came out with the ridiculous story a couple of weeks ago to make it seem that Reduce It was a flawed trial whose results should be thrown out were able to follow up with another by getting two spineless participants in the FDA's 2019 panel to say they'd change their votes today.

Amarin doesn't need to be a Big Pharma to write a coherent response to the allegations that, if true, would demolish the company and its product once and for all. Amarin just needs one professional who is skilled at image and reputation control. The FDA itself studied the Mineral Oil controversy and issued its own report to refute it after the challenge filed by the short sellers-driven filing they received when they were considering Vascepa's approval for the heart indication. Amarin also has the results of other studies it conducted that showed Mineral Oil was not a factor in the results.

Instead of issuing a strongly worded, full-throated response to the false allegations two weeks ago, it issued a press release with its own analysis of the study it funded that was, quite simply, hard to understand and decipher and which contained no real response to the false allegations that had been made against it.

Now I can excuse that KM's expertise (allegedly) is in marketing rather than public relations, but as the president of the company, he has an obligation to figure out how to properly respond to a missile directed at his company to eliminate the threat, especially when it's based on nonsense.

And the claim that Amarin was forced to keep JT around because of Judge Du's ruling is ridiculous and contrary to what really happened. In fact, because of the Du ruling, he was forced to give up much of the control of the company to KM about six months after the Du decision and his full ouster was announced six months after that.

To me, Amarin's inability to refute the, as Dr. Bhatt calls it, "silly" Mineral Oil controversy is a continuation of the very pattern of operations that led to the Judge Du ruling. Amarin, though its lawyers, was unable to articulate why Vascepa was not an "obvious" creation, but in fact was a surprising and unique creation that few in the medical community were willing to accept. And still aren't.